KYNTRA BIO, INC. (KYNB) Total liabilities 2016–2025
KYNTRA BIO, INC. (KYNB) total liabilities at each fiscal year-end, per SEC filings.
$115.1MFY2025 · since FY2016: $294.4M → $115.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $115.1M | -71.1% |
| FY2024 | $398.2M | -32.0% |
| FY2023 | $585.7M | -4.2% |
| FY2022 | $611.6M | +12.3% |
| FY2021 | $544.7M | +41.3% |
| FY2020 | $385.4M | +19.7% |
| FY2019 | $322.0M | -8.6% |
| FY2018 | $352.1M | +0.3% |
| FY2017 | $350.9M | +19.2% |
| FY2016 | $294.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice